K. Heerlein

531 total citations
15 papers, 383 citations indexed

About

K. Heerlein is a scholar working on Pharmacology, Neurology and Psychiatry and Mental health. According to data from OpenAlex, K. Heerlein has authored 15 papers receiving a total of 383 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmacology, 6 papers in Neurology and 5 papers in Psychiatry and Mental health. Recurrent topics in K. Heerlein's work include Treatment of Major Depression (6 papers), Myasthenia Gravis and Thymoma (3 papers) and Acute Ischemic Stroke Management (3 papers). K. Heerlein is often cited by papers focused on Treatment of Major Depression (6 papers), Myasthenia Gravis and Thymoma (3 papers) and Acute Ischemic Stroke Management (3 papers). K. Heerlein collaborates with scholars based in Germany, United Kingdom and United States. K. Heerlein's co-authors include Andreas Schulze, Peter Bärtsch, Heimo Mairbäurl, Werner Hacke, Peter A. Ringleb, Christoph Gumbinger, M. Sýkora, Jennifer Diedler, Brigitte Wildemann and Stefan Rohde and has published in prestigious journals such as Neurology, Stroke and Journal of Affective Disorders.

In The Last Decade

K. Heerlein

13 papers receiving 378 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. Heerlein Germany 9 134 131 100 58 46 15 383
Karl-Friedrich Amthor Norway 7 67 0.5× 100 0.8× 47 0.5× 71 1.2× 25 0.5× 14 402
Alessandro Davoli Italy 11 61 0.5× 115 0.9× 24 0.2× 11 0.2× 59 1.3× 12 349
Katrin Pape Germany 8 102 0.8× 36 0.3× 26 0.3× 169 2.9× 15 0.3× 18 619
Shaokuan Fang China 10 53 0.4× 42 0.3× 12 0.1× 46 0.8× 18 0.4× 31 263
Ewa Krzystanek Poland 10 77 0.6× 45 0.3× 11 0.1× 18 0.3× 15 0.3× 49 300
P. Bouloux United Kingdom 12 73 0.5× 77 0.6× 24 0.2× 8 0.1× 19 0.4× 17 471
Gian Carlo Andrioli Italy 13 123 0.9× 120 0.9× 42 0.4× 15 0.3× 44 1.0× 19 891
Arash Salardini United States 13 83 0.6× 39 0.3× 28 0.3× 32 0.6× 50 1.1× 45 545
Felix J. Bode Germany 8 131 1.0× 95 0.7× 7 0.1× 15 0.3× 27 0.6× 34 476
Alicia Zha United States 13 69 0.5× 99 0.8× 19 0.2× 4 0.1× 32 0.7× 33 421

Countries citing papers authored by K. Heerlein

Since Specialization
Citations

This map shows the geographic impact of K. Heerlein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Heerlein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Heerlein more than expected).

Fields of papers citing papers by K. Heerlein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Heerlein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Heerlein. The network helps show where K. Heerlein may publish in the future.

Co-authorship network of co-authors of K. Heerlein

This figure shows the co-authorship network connecting the top 25 collaborators of K. Heerlein. A scholar is included among the top collaborators of K. Heerlein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Heerlein. K. Heerlein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
3.
Cai, Qing, et al.. (2023). EE403 Direct and Indirect Costs Among Employed Patients with Myasthenia Gravis in Sweden. Value in Health. 26(6). S133–S133.
4.
Cai, Qing, et al.. (2023). HSD35 Treatment and Dosage Patterns of Oral Corticosteroids Among Patients With Myasthenia Gravis: A Tale of Two Countries. Value in Health. 26(12). S300–S300. 1 indexed citations
5.
Heerlein, K., Thomas Frodl, Albino J. Oliveira‐Maia, et al.. (2021). Real-world evidence from a European cohort study of patients with treatment resistant depression: Healthcare resource utilization. Journal of Affective Disorders. 298(Pt A). 442–450. 22 indexed citations
6.
Diekamp, Bettina, Dong‐Jing Fu, R. Charles Murray, et al.. (2021). Effect of Concomitant Benzodiazepine Use on Efficacy and Safety of Esketamine Nasal Spray in Patients with Major Depressive Disorder and Acute Suicidal Ideation or Behavior: Pooled Randomized, Controlled Trials. Neuropsychiatric Disease and Treatment. Volume 17. 2347–2357. 14 indexed citations
7.
Heerlein, K., Giulio Perugi, Christian Otte, et al.. (2021). Real-world evidence from a European cohort study of patients with treatment resistant depression: Treatment patterns and clinical outcomes. Journal of Affective Disorders. 290. 334–344. 45 indexed citations
8.
Shrestha, Anshu, et al.. (2020). Incremental Health Care Burden of Treatment-Resistant Depression Among Commercial, Medicaid, and Medicare Payers. Psychiatric Services. 71(6). 593–601. 6 indexed citations
9.
Heerlein, K., Allan H. Young, Christian Otte, et al.. (2020). Real-world evidence from a European cohort study of patients with treatment resistant depression: Baseline patient characteristics. Journal of Affective Disorders. 283. 115–122. 34 indexed citations
10.
DiBernardo, Allitia, et al.. (2018). Association of Treatment Resistant Depression with Healthcare Resource Utilization and Physician Satisfaction with Disease Management. Value in Health. 21. S188–S188. 2 indexed citations
11.
Gumbinger, Christoph, et al.. (2011). Improved Prediction of Poor Outcome After Thrombolysis Using Conservative Definitions of Symptomatic Hemorrhage. Stroke. 43(1). 240–242. 73 indexed citations
12.
Diedler, Jennifer, M. Sýkora, Philipp Hahn, et al.. (2010). Low hemoglobin is associated with poor functional outcome after non-traumatic, supratentorial intracerebral hemorrhage. Critical Care. 14(2). R63–R63. 58 indexed citations
13.
Rocco, Alessandro, K. Heerlein, Jennifer Diedler, et al.. (2010). Microalbuminuria in Cerebrovascular Disease: A Modifiable Risk Factor?. International Journal of Stroke. 5(1). 30–34. 15 indexed citations
14.
Heerlein, K., Sven Jarius, Christian Jacobi, et al.. (2008). Aquaporin-4 antibody positive longitudinally extensive transverse myelitis following varicella zoster infection. Journal of the Neurological Sciences. 276(1-2). 184–186. 40 indexed citations
15.
Heerlein, K., et al.. (2004). Hypoxia Decreases Cellular ATP Demand and Inhibits Mitochondrial Respiration of A549 Cells. American Journal of Respiratory Cell and Molecular Biology. 32(1). 44–51. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karl-Friedrich Amthor Breakdown of academic impact, for papers by Alessandro Davoli Breakdown of academic impact, for papers by Katrin Pape Breakdown of academic impact, for papers by Shaokuan Fang Breakdown of academic impact, for papers by Ewa Krzystanek Breakdown of academic impact, for papers by P. Bouloux Breakdown of academic impact, for papers by Gian Carlo Andrioli Breakdown of academic impact, for papers by Arash Salardini Breakdown of academic impact, for papers by Felix J. Bode Breakdown of academic impact, for papers by Alicia Zha
Rankless by CCL
2026